Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,990
+15.28%
|
$1,669,910
$209.09 P/Share
|
|
Mar 15
2021
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,574
-14.71%
|
$3,045,966
$209.09 P/Share
|
|
Mar 15
2021
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
32,896
+24.93%
|
$6,875,264
$209.09 P/Share
|
|
Mar 15
2021
|
Bryan T Durkin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,975
-6.93%
|
$1,248,775
$209.09 P/Share
|
|
Mar 15
2021
|
Bryan T Durkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,038
+14.86%
|
$3,142,942
$209.09 P/Share
|
|
Mar 15
2021
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-7.44%
|
$713,526
$209.09 P/Share
|
|
Mar 15
2021
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,460
+15.56%
|
$1,768,140
$209.09 P/Share
|
|
Mar 15
2021
|
Kevin Kometer Sr MD Chief Information Office |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-4.39%
|
$713,526
$209.09 P/Share
|
|
Mar 15
2021
|
Kevin Kometer Sr MD Chief Information Office |
BUY
Grant, award, or other acquisition
|
Direct |
8,460
+9.8%
|
$1,768,140
$209.09 P/Share
|
|
Mar 15
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-5.99%
|
$547,580
$209.09 P/Share
|
|
Mar 15
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,048
+13.87%
|
$1,473,032
$209.09 P/Share
|
|
Mar 15
2021
|
John W. Pietrowicz Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,806
-7.36%
|
$795,454
$209.09 P/Share
|
|
Mar 15
2021
|
John W. Pietrowicz Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,398
+15.37%
|
$1,964,182
$209.09 P/Share
|
|
Mar 15
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-18.1%
|
$662,112
$209.09 P/Share
|
|
Mar 15
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
7,990
+31.34%
|
$1,669,910
$209.09 P/Share
|
|
Mar 15
2021
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-1.12%
|
$45,144
$209.09 P/Share
|
|
Mar 15
2021
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
734
+3.67%
|
$153,406
$209.09 P/Share
|
|
Mar 15
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,771
-13.41%
|
$788,139
$209.09 P/Share
|
|
Mar 15
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
BUY
Grant, award, or other acquisition
|
Direct |
8,460
+23.12%
|
$1,768,140
$209.09 P/Share
|
|
Mar 15
2021
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-3.46%
|
$80,883
$209.09 P/Share
|
|
Mar 15
2021
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,316
+10.52%
|
$275,044
$209.09 P/Share
|
|
Mar 15
2021
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,599
-4.14%
|
$543,191
$209.09 P/Share
|
|
Mar 15
2021
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,578
+17.28%
|
$1,374,802
$209.09 P/Share
|
|
Mar 11
2021
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
1,500
-5.1%
|
$307,500
$205.46 P/Share
|
|
Mar 05
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.93%
|
$319,500
$213.0 P/Share
|
|
Feb 26
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Open market or private sale
|
Direct |
10,000
-18.56%
|
$2,010,000
$201.4 P/Share
|
|
Feb 26
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Open market or private sale
|
Indirect |
7,335
-17.14%
|
$1,459,665
$199.09 P/Share
|
|
Feb 19
2021
|
Kevin Kometer Sr MD Chief Information Office |
SELL
Open market or private sale
|
Direct |
8,000
-3.52%
|
$1,560,000
$195.93 P/Share
|
|
Feb 19
2021
|
Bryan T Durkin Director |
SELL
Open market or private sale
|
Direct |
11,000
-6.91%
|
$2,145,000
$195.72 P/Share
|
|
Feb 12
2021
|
Dennis Suskind Director |
SELL
Open market or private sale
|
Direct |
1,000
-28.05%
|
$183,000
$183.32 P/Share
|
|
Jan 07
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.78%
|
$297,000
$198.0 P/Share
|
|
Dec 31
2020
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,424
-3.96%
|
$4,081,168
$182.05 P/Share
|
|
Dec 21
2020
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,300
-5.48%
|
$418,600
$182.0 P/Share
|
|
Dec 16
2020
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
69
-0.37%
|
$12,489
$181.72 P/Share
|
|
Dec 14
2020
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Open market or private sale
|
Direct |
6,208
-12.65%
|
$1,105,024
$178.41 P/Share
|
|
Dec 14
2020
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,059
-14.01%
|
$734,679
$181.02 P/Share
|
|
Dec 14
2020
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
400
-1.34%
|
$71,200
$178.44 P/Share
|
|
Dec 01
2020
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
800
-2.61%
|
$142,400
$178.6 P/Share
|
|
Dec 01
2020
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,188
-7.85%
|
$573,840
$180.0 P/Share
|
|
Dec 01
2020
|
John W. Pietrowicz Sr MD Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.58%
|
$900,000
$180.0 P/Share
|
|
Dec 01
2020
|
John W. Pietrowicz Sr MD Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.28%
|
$270,000
$54.37 P/Share
|
|
Nov 02
2020
|
Ken Vroman Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
4,541
-31.49%
|
$690,232
$152.63 P/Share
|